Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID
Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
